Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 46,300 | 47,942 | 54,357 | 56,021 | 53,872 |
| Operating Income | -46,300 | -47,942 | -54,357 | -56,021 | -53,872 |
| Interest Expense | 3,429 | 3,500 | 3,457 | 3,475 | 3,481 |
| Other Income | 7,233 | 2,277 | 2,050 | 133 | 887 |
| Pre-tax Income | -42,496 | -49,165 | -55,764 | -59,363 | -56,466 |
| Net Income Continuous | -42,496 | -49,165 | -55,764 | -59,363 | -56,466 |
| Net Income | $-42,496 | $-49,165 | $-55,764 | $-59,363 | $-56,466 |
| EPS Basic Total Ops | -0.45 | -0.52 | -0.56 | -0.65 | -0.74 |
| EPS Basic Continuous Ops | -0.45 | -0.52 | -0.56 | -0.65 | -0.74 |
| EPS Diluted Total Ops | -0.45 | -0.52 | -0.56 | -0.65 | -0.74 |
| EPS Diluted Continuous Ops | -0.45 | -0.52 | -0.56 | -0.65 | -0.74 |
| EBITDA(a) | $-46,316 | $-47,981 | $-54,108 | $-55,015 | $-52,454 |